Germline counterparts of oncogenic mutations: who gives a JAK?.

Germline counterparts of oncogenic mutations: who gives a JAK?.

Dades bibliogràfiques
Autors principals:	Mead, A, Constantinescu, SN, Jacobsen, SE
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Germline JAK2 mutation in a family with hereditary thrombocytosis.
per: Mead, A, et al.
Publicat: (2012)

Impact of isolated germline JAK2V617I mutation on human hematopoiesis.
per: Mead, A, et al.
Publicat: (2013)

Germline activating JAK2-mutation in a family with hereditary thrombocytosis
per: Mead, A, et al.
Publicat: (2012)

Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors
per: Tekla Hornakova, et al.
Publicat: (2011-06-01)

Germline Activating JAK2 V617I Mutation, in a Family with Hereditary Thrombocytosis
per: Mead, A, et al.
Publicat: (2011)

Novel germline JAK2R715T mutation causing PV-like erythrocytosis in 3 generations. Amelioration by Ropeg-Interferon
per: Song, J, et al.
Publicat: (2024)

Germline JAK2 L611S mutation in a child with thrombocytosis
per: Bernard Aral, et al.
Publicat: (2018-08-01)

Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
per: Jie Yang, et al.
Publicat: (2021-04-01)

Oncogenic Cooperation Between IL7R-JAK-STAT Pathway Mutations
per: Inge Lodewijckx, et al.
Publicat: (2021-09-01)

P996: A NOVEL GERMLINE GAIN-OF-FUNCTION JAK2 MUTATION: L604F
per: Lukas Dvoracek, et al.
Publicat: (2023-08-01)

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
per: Zhuanghui Hao, et al.
Publicat: (2024-01-01)

Degrading JAK2 in ALL by ruxolitinib-based PROTACs
per: Constantinescu, SN, et al.
Publicat: (2021)

A Vietnamese MEN2A syndrome patient with C634G germline mutation of the RET proto-oncogene
per: Pham Le Bich Hang, et al.
Publicat: (2019-12-01)

Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis
per: Derek W. Brown, et al.
Publicat: (2022-09-01)

Comparing the quality of life in adults who stutter with their normal counterparts
per: Banafsheh Mansuri, et al.
Publicat: (2013-06-01)

Counterpart
per: Netherlands Universities Foundation for International Cooperation
Publicat: (1984)

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
per: Reckzeh, K, et al.
Publicat: (2012)

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
per: Reckzeh, K, et al.
Publicat: (2012)

JAK signaling regulates germline cyst breakdown and primordial follicle formation in mice
per: Kun Huang, et al.
Publicat: (2018-01-01)

Comparing the Lifestyle of Mothers who Have Memorized the Quran and their Counterparts in Tehran
per: Ahad Navidi, et al.
Publicat: (2017-11-01)

Germline Variants in Proto-Oncogenes and Tumor Suppressor Genes in Women with Cervical Cancer
per: Ksenia Lenkova, et al.
Publicat: (2024-10-01)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
per: Reina E Ito, et al.
Publicat: (2021-01-01)

Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel <I>GFI1B</I> germline mutation
per: Michela Faleschini, et al.
Publicat: (2021-01-01)

Counterparts and actuality
per: Fara, M, et al.
Publicat: (2005)

Counterparts and actuality
per: Fara, M, et al.
Publicat: (2005)

Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain
per: Juuli Raivola, et al.
Publicat: (2018-12-01)

A germline RET proto-oncogene mutation in multiple members of an Arab family with variable onset of MEN type 2A-associated clinical manifestations
per: Makia Marafie, et al.
Publicat: (2017-04-01)

Germline Mutations for Kidney Volume in ADPKD
per: Hiroshi Kataoka, et al.
Publicat: (2022-03-01)

"Women Who Don't Give a Crap".
per: Holly Tabor
Publicat: (2015-12-01)

Decoding germline de novo point mutations
per: Goriely, A
Publicat: (2016)

Germline CDH1 mutations in bilateral lobular carcinoma in situ.
per: Petridis, C, et al.
Publicat: (2014)

RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability
per: Edwin Chen, et al.
Publicat: (2015-12-01)

New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis
per: Florence Pasquier, et al.
Publicat: (2018-04-01)

Actuality for counterpart theorists
per: Russell, J
Publicat: (2013)

Counterpart Theory and Actuality
per: Milford, J
Publicat: (2024)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
per: Inge Govaerts, et al.
Publicat: (2019-12-01)

“3D Counterpart Analysis”: A Novel Method for Enlow’s Counterpart Analysis on CBCT
per: Michele D’Attilio, et al.
Publicat: (2022-10-01)

Monitoring of radiation-induced germline mutation in humans
per: YE Dubrova
Publicat: (2003-09-01)

Germline PTEN mutations are rare and highly penetrant
per: Rustad Cecilie F, et al.
Publicat: (2006-12-01)

Sex differences in oncogenic mutational processes
per: Li, CH, et al.
Publicat: (2020)